The paper provides a brief summary of the current understanding of the cholinergic system involvement in Alzheimer’s disease progression in relation to the recent status of the available cholinesterase inhibitors, as effective therapeutic options. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.